Boston Scientific Corporation Stock price

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:02 2023-12-01 pm EST Intraday chart for Boston Scientific Corporation 5-day change 1st Jan Change
56.14 USD +0.45% +0.92% +21.33%
Sales 2023 * 14.11 B Sales 2024 * 15.30 B Capitalization 82.24 B
Net income 2023 * 1,528 M Net income 2024 * 2,082 M EV / Sales 2023 *
6,31x
Net Debt 2023 * 6,787 M Net Debt 2024 * 4,455 M EV / Sales 2024 *
5,67x
P/E ratio 2023 *
53,7x
P/E ratio 2024 *
38,2x
Employees 45,000
Yield 2023 *
-
Yield 2024 *
-
Free-Float 84.57%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.45%
1 week+0.92%
Current month+0.45%
1 month+6.89%
3 months+4.70%
6 months+8.34%
Current year+21.33%
More quotes
1 week
54.91
Extreme 54.91
56.22
1 month
50.84
Extreme 50.84
56.22
Current year
44.35
Extreme 44.35
56.22
1 year
44.35
Extreme 44.35
56.22
3 years
33.42
Extreme 33.42
56.22
5 years
24.10
Extreme 24.1
56.22
10 years
11.10
Extreme 11.1
56.22
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 2011
Director of Finance/CFO 57 1995
Chief Tech/Sci/R&D Officer 50 2015
Members of the board TitleAgeSince
Director/Board Member 60 2021
Director/Board Member 68 2015
Director/Board Member 71 2014
More insiders
Date Price Change Volume
23-12-01 56.14 +0.45% 4,730,456
23-11-30 55.89 +0.81% 8,346,178
23-11-29 55.44 +0.93% 4,780,411
23-11-28 54.93 -1.36% 6,450,749
23-11-27 55.69 +0.11% 5,313,739

Delayed Quote Nyse, December 01, 2023 at 04:00 pm EST

More quotes
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (61.5%): products used in cardiology surgeries (28.4% of net sales), cardiac rhythm management (26.8%), peripheral surgeries (24.2%), electrophysiology tests (7.5%) and other (13.1%); - endodontic surgery (31.3%): equipment used in endoscopy (55.6% of net sales) and urology (44.4%); - neuromodulation (7.2%). The United States account for 60.2% of net sales.
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
56.14USD
Average target price
60.12USD
Spread / Average Target
+7.08%
Consensus
  1. Stock
  2. Equities
  3. Stock Boston Scientific Corporation - Nyse
Secure and Increase the Performance of your Investments with our Team of Experts at your Side
Securing my Investments
fermer